Si prevede che il mercato della matrice extracellulare raggiungerà i 52,72 milioni di dollari entro il 2028 dai 31,49 milioni di dollari del 2021. Si stima che crescerà a un CAGR del 7,6% dal 2021 al 2028.
La matrice extracellulare è presente nella parte esterna dei tessuti e aiuta i tessuti a legare le cellule con il collagene. È costituito da proteine strutturali, glicoproteine, glicosaminoglicani e proteoglicani. La matrice extracellulare consente alle cellule riceventi di ricrescere e, quindi, viene utilizzata in varie applicazioni, comprese le procedure di riparazione cardiaca e vascolare. Diversi fattori, come il significativo aumento dell’incidenza di malattie cardiovascolari e traumi e un aumento delle procedure di ricostruzione vascolare, stanno stimolando la crescita del mercato della matrice extracellulare . Tuttavia, le sfide legate all’utilizzo della matrice extracellulare decellularizzata ostacolano la crescita del mercato.
Personalizza la ricerca in base alle tue esigenze
Possiamo ottimizzare e personalizzare l'analisi e l'ambito che non sono soddisfatti dalle nostre offerte standard. Questa flessibilità ti aiuterà a ottenere le informazioni esatte necessarie per la pianificazione aziendale e il processo decisionale.
Mercato della matrice extracellulare: approfondimenti strategici
CAGR (2021 - 2028)7,6%- Dimensione del mercato 2021:
31,49 milioni di dollari - Dimensione del mercato nel 2028:
52,72 milioni di dollari
Dinamiche di mercato
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Giocatori chiave
- Anteris
- Aziyo Biologics, Inc
- Gruppo Coloplast
- Cook Biotech, Inc
- DSM Biomedico
- Baster
- Medtronic
- Merck KGaA
- MTF biologici
Panoramica regionale
- Nord America
- Europa
- Asia-Pacifico
- America meridionale e centrale
- Medio Oriente e Africa
Segmentazione del mercato
- Bovino
- Suino
- Altra materia prima
- Riparazione dei tessuti molli
- Riparazione durale
- Guarigione delle ferite
- Riparazione cardiaca
- Riparazione del pericardio
- Riparazione e ricostruzione vascolare
- Il PDF di esempio mostra la struttura del contenuto e la natura delle informazioni con analisi qualitative e quantitative.
Approfondimenti di mercato
L’aumento dell’incidenza di disturbi e traumi cardiovascolari stimola la crescita del mercato della matrice extracellulare
L’aumento significativo dei casi di traumi ortopedici e malattie cardiovascolari è il fattore principale alla base della crescita del mercato globale della matrice extracellulare. Come parte del trattamento, la matrice extracellulare offre numerosi vantaggi nel trattamento di diverse lesioni croniche causate da interventi chirurgici, incidenti, malattie croniche e altri incidenti. Inoltre, l’incidenza dell’insufficienza cardiaca e dell’infarto miocardico è in aumento tra la popolazione che invecchia. Il trattamento minimamente invasivo per queste procedure di trattamento cardiovascolare richiede una matrice extracellulare. Un paziente affetto da malattie cardiache non riesce a ripristinare le proprietà funzionali del tessuto cardiaco. La capacità della matrice extracellulare di ricrescere e promuovere la riparazione e la rigenerazione adattativa consente ai pazienti di recuperare le loro normali funzioni. Inoltre, ha mostrato risultati clinici promettenti per l’ingegneria dei tessuti nel trattamento delle malattie cardiovascolari e di altre condizioni sanitarie.
Inoltre, si prevede che la crescente incidenza delle malattie cardiovascolari stimolerà la crescita della matrice extracellulare. Ad esempio, secondo i dati dell’OMS pubblicati nel 2019, si stima che 17,9 milioni di persone siano morte a causa di malattie cardiovascolari nel 2019, pari al 32% di tutti i decessi globali. Di questi decessi, l’85% è dovuto ad infarto e ictus. Secondo il rapporto sulle statistiche europee sulle malattie cardiovascolari del 2017, in Europa, ogni anno le malattie cardiovascolari (CVD) causano 3,9 milioni di decessi e oltre 1,8 milioni di decessi nell’Unione Europea (UE).
Approfondimenti basati sulle materie prime
In base alla materia prima, il mercato della matrice extracellulare è segmentato in materie prime bovine, suine e altre. Si prevede che il segmento suino deterrà la quota maggiore del mercato, mentre si prevede che il segmento bovino registrerà il CAGR più elevato durante il periodo di previsione.
In base all'applicazione, il mercato della matrice extracellulare è stato segmentato in riparazione dei tessuti molli, riparazione durale , guarigione delle ferite, riparazione cardiaca, riparazione pericardica e riparazione e ricostruzione vascolare. È probabile che il segmento della riparazione dei tessuti molli rappresenti una quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento della riparazione e ricostruzione vascolare registrerà un CAGR più elevato nel mercato durante il periodo di previsione.
Varie aziende che operano nel mercato della matrice extracellulare stanno adottando strategie di marketing, come lanci di prodotti, fusioni e acquisizioni, collaborazioni, innovazioni di prodotto ed espansioni del portafoglio di prodotti per espandere la propria presenza in tutto il mondo, mantenere il marchio e soddisfare la crescente domanda da parte degli utenti finali. .
Ambito del rapporto di mercato della matrice extracellulare
Attributo del rapporto | Dettagli |
---|---|
Dimensioni del mercato nel 2021 | 31,49 milioni di dollari |
Dimensioni del mercato entro il 2028 | 52,72 milioni di dollari |
CAGR globale (2021-2028) | 7,6% |
Dati storici | 2019-2020 |
Periodo di previsione | 2022-2028 |
Segmenti coperti | Per materia prima
|
Regioni e paesi coperti | Nord America
|
Leader di mercato e profili aziendali chiave |
|
- Il PDF di esempio mostra la struttura del contenuto e la natura delle informazioni con analisi qualitative e quantitative.
Profili aziendali
- Anteris
- Aziyo Biologics, Inc
- Gruppo Coloplast
- Cook Biotech, Inc
- DSM Biomedico
- Baster
- Medtronic
- Merck KGaA
- MTF biologici
- Smith e nipote
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global extracellular matrix market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the rising prevalence of wounds and injuries. The growth of the market is mainly driven by the significant rise in cardiovascular disorders among the American population. And, Asia Pacific is the fastest-growing region growing at the CAGR of 8.2% during the forecast period.
The extracellular matrix market majorly consists of the players such as Anteris, Aziyo Biologics, Inc., Coloplast Group, Cook Biotech, Inc., DSM Biomedical, Baxter International, Inc., Medtronic, Merck KGaA, MTF Biologics, and Smith & Nephew, among others
The soft tissue repair segment dominated the global extracellular matrix market and accounted for the largest revenue share of 24.11% in 2021.
The Porcine segment dominated the global extracellular matrix market and held the largest revenue share of 43.76% in 2021.
Extracellular matrix is present in the outer side of the tissues and it helps tissues to bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans and proteoglycans. Extracellular matrix enables recipient cells to regrow and thus it is used in various applications which include cardiac and vascular repair procedure.
Key factors that are driving the growth of this market are rising incidence of cardiovascular diseases and trauma along with increase in vascular reconstruction procedures.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Extracellular Matrix Market
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.